Drug intelligence / Profile preview

amentoflavone

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal (investigational, Animal Studies)
01

Overview

**Amentoflavone** is a naturally occurring biflavonoid formed by the oxidative coupling of two apigenin molecules at positions C-3 (hydroxyphenyl ring) and C-8 (chromene ring)[2][5][8][7]. It is found in a variety of plants such as *Selaginella tamariscina*, *Ginkgo biloba*, *Hypericum perforatum* (St. John’s Wort), and others[4][7]. Amentoflavone exhibits **multifunctional biological activity**: it acts as an anti-inflammatory, antioxidant, antiviral, antidiabetic, neuroprotective, anticancer, anti-microbial, anti-senescence, and anti-fungal agent[1][7][13]. Mechanistically, it inhibits signaling pathways like ERK, NF-κB, PI3K/Akt, GLI-1/IL-6/STAT3, and enzymes such as cathepsin B, CYP3A4, CYP2C9, group II phospholipase A2, and cyclooxygenase[1][4][10][14][16]. It also antagonizes the κ-opioid receptor and is a negative allosteric modulator at the allosteric benzodiazepine site of the GABA_A receptor[4][16]. Recent research highlights its inhibition of SARS-CoV-2 via strong binding to 3CLpro (main protease), spike protein RBD, and RNA-dependent RNA polymerase, as well as its suppression of fatty acid synthase[1][6][13]. Pharmacokinetic studies suggest low oral bioavailability due to rapid metabolism[7]. While clinical development is ongoing for antiviral indications (notably COVID-19), most evidence is preclinical and pharmacological[6]. No brand products or commercial formulations with amentoflavone as a single agent are currently approved.

Other names
amenthoflavonetridemethylsciadopitysindidemethyl-ginkgetin3',8''-biapigenin1617-53-4
02

Targets

15-LOX (Lysyl Oxidase)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)CYP3A4 (Cytochrome P450 3A4)CTSB (Cathepsin B)Mpro (3C-like proteinase of SARS-CoV-2)RdRp (Coronavirus RNA-dependent RNA polymerase)RBD (SARS-CoV-2 spike receptor-binding domain)TYR (Tyrosinase)Sucrase-IsomaltaseCOXMAPK3 (Mitogen-activated protein kinase 1)FASN (Fatty acid synthase)GABRR (GABA-A receptor subunit rho)PLA2G2A (Secretory phospholipase A2 group IIA)KOR (Kappa opioid receptor)

Beyond the preview

Go deeper on amentoflavone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amentoflavone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call